Exelixis Inc at Credit Suisse Healthcare Conference (Virtual) Transcript
© -
There we go. Hello, everyone. Welcome to the second day of the Credit Suisse Global Virtual Health Care Conference. My name is Evan Seigerman. I'm the senior biopharma analyst here at Credit Suisse. And hopefully, next year, we'll be in person, but Zoom has to suffice for now. And with me to kind of close out the day on my schedule, we have Exelixis, and from Exelixis, we have Michael Morrissey, President and CEO.
So before we jump in with Q&A, Michael, I was wondering if you could just give us an update. I know you had your third quarter call last week. Tell us kind of what's happening with Exelixis and get us up to speed, and then we can jump into questions.
Yes. Sounds good. Thanks again for having us. We've had a very packed day of one-on-ones.
- ©
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
